Person

Paul J. Clancy

Director, Incyte

Current S&P 500 boards
1
Current roles
1
Open-market buys
$0
Open-market sales
$7.2M

Current roles

From Section 16 filings (Forms 3, 4 and 5) in the last 13 months.

Past roles

“Last filing” is the latest Form 3/4/5 for that company, an upper bound on the end date.

  • BIIB
    Biogen
    Executive VP and CFO
    2016 or earlier – last filing Apr 2017

Sits alongside

People who currently share a board or management team with this person.

Open-market trades

Purchases and sales reported on Form 4 at S&P 500 companies.

DateCompanyTypeSharesPriceValue
May 19, 2026INCYSale15,000$94.93$1.4M
Apr 25, 2017BIIBSale9,892$290.00$2.9M
Mar 13, 2017BIIBSale9,891$291.55$2.9M

SEC reporting-owner ID (CIK) 1409601 · all filings on EDGAR